UMDV.AS vs. IMAE.AS
UMDV.AS (iShares US Medical Devices UCITS ETF) and IMAE.AS (iShares Core MSCI Europe UCITS ETF EUR (Acc)) are both exchange-traded funds - UMDV.AS is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while IMAE.AS is a Europe Equities fund tracking the MSCI Europe NR EUR. Both are passively managed. Over the past 5 years, UMDV.AS returned -1.58%/yr vs 8.94%/yr for IMAE.AS. A 0.53 correlation means they provide meaningful diversification when combined. UMDV.AS charges 0.25%/yr vs 0.20%/yr for IMAE.AS.
Performance
UMDV.AS vs. IMAE.AS - Performance Comparison
Loading charts...
Different Trading Currencies
UMDV.AS is traded in USD, while IMAE.AS is traded in EUR. To make them comparable, the IMAE.AS values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, UMDV.AS achieves a -21.33% return, which is significantly lower than IMAE.AS's 6.29% return.
UMDV.AS
- 1D
- 3.64%
- 1M
- -0.76%
- YTD
- -21.33%
- 6M
- -22.09%
- 1Y
- -20.45%
- 3Y*
- -1.79%
- 5Y*
- -1.58%
- 10Y*
- —
IMAE.AS
- 1D
- 0.65%
- 1M
- 2.62%
- YTD
- 6.29%
- 6M
- 9.52%
- 1Y
- 18.12%
- 3Y*
- 16.76%
- 5Y*
- 8.94%
- 10Y*
- 9.41%
UMDV.AS vs. IMAE.AS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
UMDV.AS iShares US Medical Devices UCITS ETF | -21.33% | 7.40% | 11.19% | 4.39% | -20.14% | 23.03% | 12.03% |
IMAE.AS iShares Core MSCI Europe UCITS ETF EUR (Acc) | 6.29% | 35.83% | 2.15% | 19.65% | -14.76% | 17.10% | 13.78% |
Correlation
The correlation between UMDV.AS and IMAE.AS is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Aug 7, 2020 | 0.53 |
The correlation between UMDV.AS and IMAE.AS shifts across timeframes, from 0.34 (1 year) to 0.53 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UMDV.AS vs. IMAE.AS — Risk / Return Rank
UMDV.AS
IMAE.AS
UMDV.AS vs. IMAE.AS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares US Medical Devices UCITS ETF (UMDV.AS) and iShares Core MSCI Europe UCITS ETF EUR (Acc) (IMAE.AS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UMDV.AS | IMAE.AS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.41 | ||
| Sortino ratioReturn per unit of downside risk | -3.48 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.22 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 1.56 | -2.31 |
| Martin ratioReturn relative to average drawdown | -1.92 | 5.57 | -7.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UMDV.AS | IMAE.AS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.19 | 1.22 | -2.41 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.08 | 0.51 | -0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.52 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.37 | -0.30 |
Drawdowns
UMDV.AS vs. IMAE.AS - Drawdown Comparison
The maximum UMDV.AS drawdown since its inception was -31.59%, smaller than the maximum IMAE.AS drawdown of -35.83%. Use the drawdown chart below to compare losses from any high point for UMDV.AS and IMAE.AS.
Loading charts...
Drawdown Indicators
| UMDV.AS | IMAE.AS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.59% | -35.83% | +4.24% |
Max Drawdown (1Y)Largest decline over 1 year | -27.14% | -11.45% | -15.69% |
Max Drawdown (3Y)Largest decline over 3 years | -27.48% | -14.96% | -12.52% |
Max Drawdown (5Y)Largest decline over 5 years | -31.59% | -30.80% | -0.79% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.83% | — |
Current DrawdownCurrent decline from peak | -24.28% | -1.94% | -22.34% |
Average DrawdownAverage peak-to-trough decline | -11.43% | -8.18% | -3.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.62% | 3.23% | +7.39% |
Volatility
UMDV.AS vs. IMAE.AS - Volatility Comparison
iShares US Medical Devices UCITS ETF (UMDV.AS) has a higher volatility of 7.25% compared to iShares Core MSCI Europe UCITS ETF EUR (Acc) (IMAE.AS) at 4.96%. This indicates that UMDV.AS's price experiences larger fluctuations and is considered to be riskier than IMAE.AS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UMDV.AS | IMAE.AS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.25% | 4.96% | +2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 13.42% | 12.31% | +1.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.04% | 14.71% | +2.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.67% | 17.34% | +1.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.66% | 17.70% | +0.96% |
UMDV.AS vs. IMAE.AS - Expense Ratio Comparison
UMDV.AS has a 0.25% expense ratio, which is higher than IMAE.AS's 0.20% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
UMDV.AS vs. IMAE.AS - Dividend Comparison
Neither UMDV.AS nor IMAE.AS has paid dividends to shareholders.
Frequently Asked Questions
UMDV.AS and IMAE.AS have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IMAE.AS is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IMAE.AS is cheaper with a 0.20% expense ratio, compared with 0.25% for UMDV.AS.
UMDV.AS is categorized as Health & Biotech Equities, while IMAE.AS is Europe Equities. UMDV.AS tracks MSCI World/Health Care NR USD, while IMAE.AS tracks MSCI Europe NR EUR. Their fees differ too: 0.25% for UMDV.AS and 0.20% for IMAE.AS.
Find the right allocation for UMDV.AS and IMAE.AS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer